» Articles » PMID: 28229969

MicroRNA-144 Inhibits Hepatocellular Carcinoma Cell Proliferation, Invasion and Migration by Targeting ZFX

Overview
Journal J Biosci
Specialties Biochemistry
Biology
Date 2017 Feb 24
PMID 28229969
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNA 144 (miR-144), a small non-coding RNA, is frequently dysregulated in human several tumour progression, but its role and the underlying mechanisms in hepatocellular carcinoma (HCC) is poorly investigated. In the present study, the expression of miR-144 was firstly analysed in datasets derived from GSE21362 and TCGA, and then detected in HCC tissues and cell lines by quantitative RT-PCR (qRT-PCR) analysis. MiR-144 was shown to be significantly down-regulated in HCC tissues and cell lines. Subsequently, overexpression of miR-144 was transfected into HCC cell lines so as to investigate its biological function, including MTT, colony formation, and transwell assays. Gain of function assay revealed miR-144 remarkably inhibited cell proliferation, migration and invasion. In addition, bioinformatical analysis and luciferase reporter assay identified ZFX as a novel target of miR-144 in HCC cells, as confirmed by qRT-PCR and Western blot. Furthermore, ZFX was found to be significantly up-regulated using Oncomine database analysis. Loss of function assay further indicated knockdown of ZFX had similar effects of miR-144-mediated HCC cell proliferation and invasion. Therefore, miR-144 has been demonstrated to act as a tumour suppressor in HCC cell growth and motility by directly targeting ZFX, which implicates its potential applications in the development of HCC treatment.

Citing Articles

The miRNA-mRNA Regulatory Network in Human Hepatocellular Carcinoma by Transcriptomic Analysis From GEO.

Heidari R, Assadollahi V, Marashi S, Elahian F, Mirzaei S Cancer Rep (Hoboken). 2025; 8(1):e70098.

PMID: 39764737 PMC: 11705453. DOI: 10.1002/cnr2.70098.


Emerging role of MicroRNA-Based theranostics in Hepatocellular Carcinoma.

Toro A, Shukla S, Bansal P Mol Biol Rep. 2023; 50(9):7681-7691.

PMID: 37418086 DOI: 10.1007/s11033-023-08586-z.


Prognostic prediction and gene regulation network of in hepatocellular carcinoma based on data mining.

Ji P, Wang H, Cheng Y, Liang S J Gastrointest Oncol. 2022; 12(6):3061-3078.

PMID: 35070430 PMC: 8748036. DOI: 10.21037/jgo-21-748.


Insulin receptor substrate-1 and dishevelled 2 are negatively regulated by microRNA-144 and inhibit nasopharyngeal carcinoma cell malignancy.

An X, Jiang Y, Chen D, Chen J Exp Ther Med. 2021; 22(5):1303.

PMID: 34630658 PMC: 8461623. DOI: 10.3892/etm.2021.10738.


MicroRNA 144 inhibits cell migration and invasion and regulates inflammatory cytokine secretion through targeting toll like receptor 2 in non-small cell lung cancer.

Pu R, Pu M, Huang H, Cui Y Arch Med Sci. 2021; 17(4):1028-1037.

PMID: 34336030 PMC: 8314413. DOI: 10.5114/aoms.2020.93084.


References
1.
Tang B, Li Y, Zhao L, Yuan S, Wang Z, Li B . Stable isotope dimethyl labeling combined with LTQ mass spectrometric detection, a quantitative proteomics technology used in liver cancer research. Biomed Rep. 2014; 1(4):549-554. PMC: 3917736. DOI: 10.3892/br.2013.100. View

2.
Xiang C, Cui S, Ke Y . MiR-144 inhibits cell proliferation of renal cell carcinoma by targeting MTOR. J Huazhong Univ Sci Technolog Med Sci. 2016; 36(2):186-192. DOI: 10.1007/s11596-016-1564-0. View

3.
Yang X, Zhang X, Lu X, Jia H, Liang L, Dong Q . MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway. Hepatology. 2013; 59(5):1874-85. DOI: 10.1002/hep.26941. View

4.
Lai K, Chen J, He M, Ching A, Lau C, Lai P . Overexpression of ZFX confers self-renewal and chemoresistance properties in hepatocellular carcinoma. Int J Cancer. 2014; 135(8):1790-9. DOI: 10.1002/ijc.28819. View

5.
Higashi T, Hayashi H, Ishimoto T, Takeyama H, Kaida T, Arima K . miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells. Br J Cancer. 2015; 113(2):252-8. PMC: 4506379. DOI: 10.1038/bjc.2015.170. View